Готові списки джерел за темами / Chronic hepatitis B virus infection

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Добірка наукової літератури з теми "Chronic hepatitis B virus infection"

Автор: Grafiati
Опубліковано: 7 червня 2025
Оновлено: 2 серпня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Chronic hepatitis B virus infection".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Chronic hepatitis B virus infection"

1

Aliu, Tawakalitu Bidemi, Abafi J. Majiyebo, Amos Ndarubu Tsado, Habiba Abdulsalam Ibrahim, and Eustace B. Berinyuy. "Biology and molecular pathogenesis of hepatitis B virus infection." BIOMED natural and applied science 2, no. 2 (2022): 28–36. http://dx.doi.org/10.53858/bnas02022836.

Повний текст джерела
Анотація:
Hepatitis B virus (HBV) remains a global public health infection. Over the past several decades, the basic principles of HBV gene expression and replication as well as the viral and host determinants governing infection outcomes have been largely uncovered. The clinical manifestations of HBV infection vary from an acute and chronic form of the disease. During the acute phase of the infection, the disease manifestations vary from subclinical hepatitis to anicteric hepatitis, icteric hepatitis, and fulminant hepatitis while during the chronic infection, manifest in different from ranging from as
Стилі APA, Harvard, Vancouver, ISO та ін.
2

AHMED, EJAZ. "CHRONIC HEPATITIS B VIRUS INFECTION." Professional Medical Journal 13, no. 04 (2006): 716–20. http://dx.doi.org/10.29309/tpmj/2006.13.04.4958.

Повний текст джерела
Анотація:
Hepatitis B virus is a major health dilemma causing an enormous burden on the health care systemand a major source of patient’s suffering. Over the last decade, far-reaching research has not only led to theenhancement of present management of chronic hepatitis B, but has also revealed new options for the treatment ofthis appalling disease. Presently interferon alpha- 2b, lamivudine, adenofovir dipivoxil and tenofovir are being employedfor the management of chronic hepatitis B infection. However, extensive research is being carried out to assess theefficacy of peg- interferon, emtricitabine, en
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Paz, M. O. A., F. Brenes, P. Karayiannis, T. P. Jowett, P. J. Scheuer, and H. C. Thomas. "Chronic hepatitis B virus infection." Journal of Hepatology 3, no. 3 (1986): 371–77. http://dx.doi.org/10.1016/s0168-8278(86)80491-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Yuen, Man-Fung, Sang Hoon Ahn, Ding-Shinn Chen, et al. "Chronic Hepatitis B Virus Infection." Journal of Clinical Gastroenterology 50, no. 4 (2016): 286–94. http://dx.doi.org/10.1097/mcg.0000000000000478.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

McMahon, Brian J. "Chronic Hepatitis B Virus Infection." Medical Clinics of North America 98, no. 1 (2014): 39–54. http://dx.doi.org/10.1016/j.mcna.2013.08.004.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Seto, Wai-Kay, Ying-Ru Lo, Jean-Michel Pawlotsky, and Man-Fung Yuen. "Chronic hepatitis B virus infection." Lancet 392, no. 10161 (2018): 2313–24. http://dx.doi.org/10.1016/s0140-6736(18)31865-8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Inad, Mutlaq Alotaibi Ibrahim Hassan Almalki Rawabi Abdullah Alharbi Moroj Fadol Alreheli Areej Muteb S. Alanazi Batoul Farhoon Qari Mohammad Saud S. Aljohani Abdulrahman Faleh Almutairi. "HEPATITIS B VIRUS: A CLINICAL REVIEW." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 05, no. 11 (2018): 11864–70. https://doi.org/10.5281/zenodo.1483425.

Повний текст джерела
Анотація:
<strong><em>Introduction:</em></strong><em> Hepatitis B viral infection is the most common cause of chronic liver disease across the world and is often transmitted through sexual contact, parenteral, or vertical routes. Hepatitis b virus belongs to Hepadnaviridae family where the viral capsid bears viral genome and DNA polymerase that has reverse transcriptase activity. Affected individual present with a range of mild symptoms to symptoms of liver failure, as well as many can be asymptomatic. The disease is classified as acute and chronic based on duration and viral markers.&nbsp; <strong>Aim
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Sharipovna, Nazarova Nodira, and Shukurov Sherzod Shukhratovich. "BIOCHEMICAL CHANGES OF CHRONIC GENERALIZED PERIODONTITIS IN CHRONIC VIRAL HEPATITIS B, C AND MIXED INFECTIONS." American Journal of Medical Sciences and Pharmaceutical Research 5, no. 8 (2023): 91–98. http://dx.doi.org/10.37547/tajmspr/volume05issue08-16.

Повний текст джерела
Анотація:
Viral hepatitis (VH) belongs to the category of infectious diseases of the human body that develop under the influence of viruses, which are diverse in nature, in the ways of their spread and transmission from a patient to a healthy person and have one identical attribute - liver damage. VG is an atroponous infection, which means that their pathogens in natural conditions can only be present in the human body. In hepatitis of viral origin, pathogens have a selective similarity (tropism) to liver cells. For this reason, the early location of viruses and their replication (reproduction) are mani
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Scarsi, Kimberly K., and Kristin M. Darin. "Chronic Hepatitis B Infection: Principles of Therapy." Journal of Pharmacy Practice 22, no. 4 (2009): 359–87. http://dx.doi.org/10.1177/0897190008328692.

Повний текст джерела
Анотація:
Chronic hepatitis B is a global health concern in many resource-limited settings due to perinatal or pediatric hepatitis B virus transmission. In the United States, pediatric infection has been virtually eliminated due to maternal screening during pregnancy and the availability of an effective vaccine. However, young adults remain an at-risk group for hepatitis B virus infection due to sexual transmission and injection drug use. The frequency of progression from acute hepatitis B virus infection to chronic hepatitis B infection depends on multiple factors, including host immune function and ag
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Minuk, GY, and J. Uhanova. "Chronic Hepatitis B in Canada." Canadian Journal of Infectious Diseases 12, no. 6 (2001): 351–56. http://dx.doi.org/10.1155/2001/650313.

Повний текст джерела
Анотація:
Recent developments in the treatment and prevention of hepatitis B virus (HBV) infections warrant revisiting important epidemiological questions, such as how prevalent is chronic HBV infection in Canada, in which Canadian subpopulations are HBV prevalence rates the highest, in what percentage of infected individuals is the virus actively replicating, and how many infected Canadians are candidates for antiviral therapy? Currently available data suggest the overall prevalence of HBV-infected individuals in the general population is approximately 2%, with 5% to 10% having serological evidence of
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Дисертації з теми "Chronic hepatitis B virus infection"

1

Williams, Stephen John. "Chronic hepatitis B virus infection : prevention and treatment." Thesis, The University of Sydney, 1989. https://hdl.handle.net/2123/26390.

Повний текст джерела
Анотація:
Hepatitis B virus (HBV) infection is an increasing public health problem in Australia particularly in certain 'high-risk' subgroups of the population. In order to establish cost-effective screening and vaccination programs directed towards the control and possible eradication of HBV infection, accurate information is needed about the modes of spread and the numbers of "at risk" individuals in particular community subgroups. In addition, treatment strategies must be developed for established HBV carriers since at least 35% of such individuals will die directly related to complications of the di
Стилі APA, Harvard, Vancouver, ISO та ін.
2

駱淑芳 and Suk-fong Anna Lok. "Replication of hepatitis B virus in Chinese patients with chronic hepatitis B virus infection." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1990. http://hub.hku.hk/bib/B31981392.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Stoop, Jeroen nicolaas. "Regulatory T cells in chronic hepatitis B virus infection." [S.l.] : Rotterdam : [The Author] ; Erasmus University [Host], 2007. http://hdl.handle.net/1765/11766.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Lopes, Agnel Ross. "CD8+ T cell attrition in chronic hepatitis B virus infection." Thesis, University College London (University of London), 2008. http://discovery.ucl.ac.uk/1444224/.

Повний текст джерела
Анотація:
Hepatitis B virus (HBV)-specific CD8+ T cells are critical for a successful immune response to HBV infection. These cells are markedly diminished in patients that are unable to contain the virus and the mechanisms contributing to their depletion are not well-understood. The aim of this work was to further dissect this response in individuals with chronic infection. Studies of the HBV-specific CD8+ T cell immunodominance hierarchy demonstrated that persistent infection was associated with a hyporesponsiveness that was exacerbated with increasing antigenic load. The immunodominant core 18-27-spe
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Yuen, Man-fung, and 袁孟峰. "Chronic hepatitis B virus infection in the Chinese: natural history, sequelae, treatment and prevention." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2000. http://hub.hku.hk/bib/B2333177X.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

劉耀南 and Yiu-nam Lau. "Interferons and tumour necrosis factor in chronic hepatitis B virus infection." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1990. http://hub.hku.hk/bib/B31981446.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Lau, Yiu-nam. "Interferons and tumour necrosis factor in chronic hepatitis B virus infection." Hong Kong : University of Hong Kong, 1990. http://sunzi.lib.hku.hk/hkuto/record.jsp?B2158879X.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Taal, Maarten Willem. "Control of Hepatitis B and C virus infection in chronic haemodialysis patients." Master's thesis, University of Cape Town, 1997. http://hdl.handle.net/11427/25675.

Повний текст джерела
Анотація:
Chronic haemodialysis patients have a high prevalence of Hepatitis B and C virus infections both of which are associated with chronic liver disease and hepatocellular carcinoma Hepatitis B virus (HBV) was identified as a frequent cause of hepatitis during the early years of chronic haemodialysis therapy and strict adherence to infection control measures alone proved inadequate to control the transmission of infection between patients. A policy of regular screening of all patients and blood donations for hepatitis B surface antigen together with isolation of positive patients to separate dialys
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Wang, Yudong. "The role of regulatory T cells in chronic hepatitis B virus infection." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B43223990.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Wang, Yudong, and 汪玉東. "The role of regulatory T cells in chronic hepatitis B virus infection." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B43223990.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Книги з теми "Chronic hepatitis B virus infection"

1

Tang, Hong, ed. Hepatitis B Virus Infection. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-13-9151-4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

1944-, Gerlich W. H., ed. Research in chronic viral hepatitis. Springer-Verlag, 1993.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Goh, Kee Tai. Epidemiology and control of hepatitis B virus infection in Singapore. Southeast Asian Medical Information Center, International Medical Foundation of Japan, 1992.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Goh, K. T. Epidemiology and control of hepatitis B virus infection in Singapore. Southeast Asian Medical Information Center, 1992.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

San Francisco (Calif). Dept. of Public Health. Communicable Disease Control Unit. Chronic hepatitis B and hepatitis C infection surveillance report: 2009, San Francisco, California. San Francisco Department of Public Health, 2010.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

San Francisco (Calif). Dept. of Public Health. Communicable Disease Control Unit. Chronic hepatitis B and hepatitis C infection surveillance report: 2010, San Francisco, California. San Francisco Department of Public Health, 2012.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

1953-, Hamatake Robert Kiyoshi, and Lau Johnson Y. N, eds. Hepatitis B and D protocols. Humana Press, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

San Francisco (Calif.). Dept. of Public Health. Communicable Disease Control Unit. Registry match: Chronic hepatitis B, hepatitis C infection and HIV : 2010, San Francisco, California. San Francisco Department of Public Health, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Green, William Finley. The first year-- hepatitis B: An essential guide for the newly diagnosed. Marlowe & Co., 2002.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Husereau, Donald Robert. Interferon-based therapies for chronic hepatitis C virus infection: An assessment of clinical outcomes. Canadian Coordinating Office for Health Technology Assessment, 2004.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Chronic hepatitis B virus infection"

1

Kurstak, Edouard. "Chronic hepatitis B virus infection." In Viral Hepatitis. Springer Vienna, 1993. http://dx.doi.org/10.1007/978-3-7091-4437-4_10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Forcione, David G., Raymond T. Chung, and Jules L. Dienstag. "Natural History of Hepatitis B Virus Infection." In Chronic Viral Hepatitis. Humana Press, 2002. https://doi.org/10.1007/978-1-59259-104-6_3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Liaw, Yun-Fan. "Natural History of Chronic Hepatitis B Virus Infection." In Viral Hepatitis. John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118637272.ch10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Albarrak, Abdulmajeed A., Ky-Dieu Tran, and Veysel Tahan. "Hepatitis D Virus Infection: Role of Hepatitis B and the Current Updates on Management." In Viral Hepatitis: Chronic Hepatitis B. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-93449-5_8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Asselah, Tarik, and Patrick Marcellin. "Chronic HBV Infection: Interferon Therapy and Long-Term Outcomes." In Hepatitis B Virus and Liver Disease. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4843-2_10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Bogler, Yael, Robert J. Wong, and Robert G. Gish. "Epidemiology and Natural History of Chronic Hepatitis B Virus Infection." In Hepatitis B Virus and Liver Disease. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-4843-2_4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Wong, Vincent Wai-Sun. "Chronic Hepatitis B Virus Infection: Noninvasive Assessment of Liver Disease." In Hepatitis B Virus and Liver Disease. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-3615-8_11.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Papatheodoridi, Margarita, and George Papatheodoridis. "Chronic Hepatitis B Virus Infection: Interferon Therapy and Long-Term Outcomes." In Hepatitis B Virus and Liver Disease. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-3615-8_12.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Lin, Chih-Lin, and Jia-Horng Kao. "Novel Biomarkers for the Management of Chronic Hepatitis B Virus Infection." In Hepatitis B Virus and Liver Disease. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-3615-8_10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Mak, Lung-Yi, and Man-Fung Yuen. "Novel Therapy for Functional Cure of Chronic Hepatitis B Virus Infection." In Hepatitis B Virus and Liver Disease. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-3615-8_19.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Chronic hepatitis B virus infection"

1

Rakić, Violeta, and Jelena Simić. "Analysis of trends in the incidence of acute hepatitis B virus infection in the Republic of Serbia in the period from 2003 to 2022." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24128r.

Повний текст джерела
Анотація:
Background: Hepatitis B virus (HBV) is a common worldwide blood-borne pathogen. WHO estimates that 254 million people were living with chronic hepatitis B infection in 2022, with 1.2 million new infections each year. In 2022, hepatitis B resulted in an estimated 1.1 million deaths, mostly from cirrhosis and hepatocellular carcinoma (primary liver cancer). Hepatitis B can be prevented by vaccines that are safe, available and effective. Chronic hepatitis B can progress to an inactive carrier state, and then, in some patients, give rise to cirrhosis and cancer of the liver, leading to death. An H
Стилі APA, Harvard, Vancouver, ISO та ін.
2

"A CROSS-SECTIONAL STUDY OF KNOWLEDGE, ATTITUDES AND PRACTICE ABOUT HEPATITIS IN A SUB-URBAN COMMUNITY IN SOUTH-WESTERN NIGERIA." In International Conference on Public Health and Humanitarian Action. International Federation of Medical Students' Associations - Jordan, 2022. http://dx.doi.org/10.56950/jhhi8301.

Повний текст джерела
Анотація:
Background: The hepatitis B virus (HBV) is a common infection that causes viral hepatitis B, which accounts for the world's most common cause of acute and chronic liver disorders. The WHO estimates 257 million people, or 3.5% of the world's population, had chronic HBV infection in 2015. July 28 every year, the world comes together under "World Hepatitis Day" (WHD) to raise awareness of the burden of viral hepatitis around the world. Objective: This study was conducted on WHD 2021 to evaluate the knowledge, attitude and practice toward hepatitis in an urban community in south-western Nigeria. M
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Ribeiro, Camilla, Katrini Martinelli, Vinícius Mello, et al. "Genetic variability of hepatitis B virus: influence on the course of infection in patients with acute and chronic hepatitis B." In International Symposium on Immunobiological. Instituto de Tecnologia em Imunobiológicos, 2021. http://dx.doi.org/10.35259/isi.2021_46590.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Steppich, Katja, Roni Souleiman, Elena Bruni та ін. "The role of CXCR6+γδ T cells in chronic hepatitis B virus (HBV) infection". У 39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0042-1760061.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Velkov, S., JJ Ott, U. Protzer, and T. Michler. "Estimation of the genotype distribution within global chronic hepatitis B virus infections." In 35. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0038-1677297.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Seidl, S. "SCREENING PROCEDURES TO PREVENT TRANSMISSION OF HEPATITIS B, NON-A,NON-B, AND AIDS BY BLOOD TRANSFUSION." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644753.

Повний текст джерела
Анотація:
Although the number of infectious agents capable of being transmitted through blood and blood products is vast, only a few cause problems in recipients of a magnitude which warrants the need for screening tests. The most important agents are Hepatitis B Virus (HBV), Hepatitis non-A,non-B (HNANB) - agents causing posttransfusion hepatitis (PTH) and the human immundeficiency viruses (HIV) responsible for transfusion associated AIDS (TAA).PTH: Prospective studies in open-heart-surgery patients demonstrated a high prevalence (8-17%) *in Spain, Italy, the United States and Israel whereas low percen
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Sharon, Ashoke, and Chung K. Chu. "Clevudine (L-FMAU): a unique antiviral agent for the treatment of chronic hepatitis B virus infection." In XIVth Symposium on Chemistry of Nucleic Acid Components. Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2008. http://dx.doi.org/10.1135/css200810239.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Kurniati, Nurul. "Analysis of Factors and Management of Hepatitis B Virus Screening in Mothers and Infants: A Scoping Review." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.67.

Повний текст джерела
Анотація:
ABSTRACT Background: The importance of screening for HBV infection is to identify the risk of perinatal transmission from infected mothers. People infected with HBV during infancy or childhood are more likely to suffer chronic infection to cirrhosis of the liver and liver cancer. Early detection and prompt treatment are essential for HBV infection. This study aimed to review the factors and management of hepatitis B virus screening in mothers and infants. Subjects and Method: A scoping review method was conducted in eight stages including (1) Identification of study problems; (2) Determining p
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Akgöllü, Ersin, Ramazan Bilgin, Hikmet Akkız, Yakup Ülger, and Berrin Yalınbaş Kaya. "Association between Chronic Hepatitis B Virus Infection and HLA Gene rs3077 and rs9277535 Polymorphisms in the Turkish population." In Annual International Conference on Advances in Biotechnology (BIOTECH 2016). Global Science & Technology Forum (GSTF), 2016. http://dx.doi.org/10.5176/2251-2489_biotech16.9.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Castro, Ana Rita Motta, Livia Lima, Larissa Bandeira, et al. "Hepatitis B: changes in epidemiological features of Afrodescendant communities in Central Brazil." In XIII Congresso da Sociedade Brasileira de DST - IX Congresso Brasileiro de AIDS - IV Congresso Latino Americano de IST/HIV/AIDS. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/dst-2177-8264-202133p142.

Повний текст джерела
Анотація:
Introduction: Hepatitis B virus (HBV) infection is still a concern in vulnerable populations. In a study performed by our team in 1999–2003 in two Afro-Brazilian communities, Furnas dos Dionísios (FD) and São Benedito (SB), high prevalence rates of HBV exposure (42.7% and 16.0%, respectively), high susceptibility to HBV (55.3% and 63.0%, respectively) and low HBV vaccination like profile rates (2.0% and 21.0%, respectively) were observed. Objective: In 2015–2016, we reassessed epidemiological and molecular features of HBV in these two communities to verify the impact of health actions adopted
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Chronic hepatitis B virus infection"

1

Tangkijvanith, Pisit. Prevalence and Clinical Significance of Hepatitis B Viral Genotypes and Mutations. Faculty of Medicine, Chulalongkorn University, 2006. https://doi.org/10.58837/chula.res.2006.24.

Повний текст джерела
Анотація:
Hepatitis B virus (HBV) infection is a major public health problem, with more than 400 million HBV carriers estimated worldwide. Chronic HBV infection is associated with a diverse clinical spectrum of liver damage ranging from asymptomatic carrier status, chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). There have been increasing lines of evidence to indicate influences of HBV genotypes and mutations on the outcome of liver disease, particularly the development of HCC. The project is aimed to study the prevalence and clinical significance of genotypes and mutations in Precore/
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Xu, Yan, Yuyang Zhao, Yong Wang, et al. Concurrent hepatic steatosis increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B or C virus infection: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.7.0099.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Hajarizadeh, Behzad, Jennifer MacLachlan, Benjamin Cowie, and Gregory J. Dore. Population-level interventions to improve the health outcomes of people living with hepatitis B: an Evidence Check brokered by the Sax Institute for the NSW Ministry of Health, 2022. The Sax Institute, 2022. http://dx.doi.org/10.57022/pxwj3682.

Повний текст джерела
Анотація:
Background An estimated 292 million people are living with chronic hepatitis B virus (HBV) infection globally, including 223,000 people in Australia. HBV diagnosis and linkage of people living with HBV to clinical care is suboptimal in Australia, with 27% of people living with HBV undiagnosed and 77% not receiving regular HBV clinical care. This systematic review aimed to characterize population-level interventions implemented to enhance all components of HBV care cascade and analyse the effectiveness of interventions. Review questions Question 1: What population-level interventions, programs
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Talal, Andrew, Marianthi Markatou, Ponni Perumalswami, et al. Facilitated Telemedicine for Underserved Populations: Management of Chronic Hepatitis C Virus Infection. The TEAM-C Study. Patient-Centered Outcomes Research Institute (PCORI), 2025. https://doi.org/10.25302/04.2025.ihs.150731640.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Також вас можуть зацікавити розширені добірки на тему "Chronic hepatitis B virus infection" для конкретних типів джерел:
Статті в журналах Дисертації Книги
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії